The
dilutive common shares that were used in the calculation of diluted earnings for 2023 are presented in the table below. The 2024 amounts
were not used as they were antidilutive. All amounts have been adjusted retroactively for the Reverse Stock Split.
Summary of Dilutive Common Shares were Excluded from Calculation of Diluted
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Shares subject to options to purchase common stock |
|
|
743,122 |
|
|
|
495,139 |
|
|
|
743,122 |
|
|
|
495,139 |
|
Unvested restricted stock units |
|
|
51,724 |
|
|
|
33,740 |
|
|
|
51,724 |
|
|
|
33,740 |
|
Shares subject to warrants to purchase common stock |
|
|
350,001 |
|
|
|
1 |
|
|
|
350,001 |
|
|
|
1 |
|
Total |
|
|
1,144,847 |
|
|
|
528,880 |
|
|
|
1,144,847 |
|
|
|
528,880 |
|
|